Education
About Us
Working with TipRanks
Follow Us
Bluebird bio Inc (BLUE)
:BLUE
Total Valuation
Bluebird Bio has a market cap or net worth of $40.53M. The enterprise value is $390.74M.
Market Cap$40.53M
Enterprise Value$390.74M
Share Statistics
Bluebird Bio has 9.79M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9.79M
Owned by Insiders9.50%
Owned by Instutions<0.01%
Financial Efficiency
Bluebird Bio’s return on equity (ROE) is 7.63 and return on invested capital (ROIC) is -106.97%.
Return on Equity (ROE)763.35%
Return on Assets (ROA)-52.30%
Return on Invested Capital (ROIC)-106.97%
Return on Capital Employed (ROCE)-194.90%
Revenue Per Employee$214,193.548
Profits Per Employee-$1,211,770.161
Employee Count248
Asset Turnover0.18
Inventory Turnover1.37
Valuation Ratios
The current PE Ratio of Bluebird Bio is -0.34. Bluebird Bio’s PEG ratio is >-0.01.
PE Ratio-0.34
PS Ratio0.96
PB Ratio-2.56
Price to Fair Value-2.56
Price to FCF-0.31
Price to Operating Cash Flow-0.31
PEG Ratio>-0.01
Income Statement
In the last 12 months, Bluebird Bio had revenue of $53.12M and earned -$300.52M in profits. Earnings per share was -$1.84.
Revenue$53.12M
Gross Profit-$23.10M
Operating Income-$316.68M
Pretax Income-$300.60M
Net Income-$300.52M
EBITDA-128.23M
Earnings Per Share (EPS)-1.84
Cash Flow
In the last 12 months, operating cash flow was -$223.69M and capital expenditures -$7.33M, giving a free cash flow of -$231.02M billion.
Operating Cash Flow-$223.69M
Free Cash Flow-$231.02M
Free Cash Flow per Share-$23.60
Dividends & Yields
Bluebird Bio pays an annual dividend of $177.66, resulting in a dividend yield of
Dividend Per Share$177.66
Dividend Yield
Payout Ratio
Free Cash Flow Yield-325.00%
Earnings Yield-297.89%
Stock Price Statistics
Beta0.62
52-Week Price Change-79.71%
50-Day Moving Average4.73
200-Day Moving Average10.13
Relative Strength Index (RSI)41.65
Average Volume (3m)429.10K
Important Dates
Bluebird Bio upcoming earnings date is May 7, 2025, After Close.
Last Earnings DateFeb 25, 2025
Next Earnings DateMay 7, 2025
Ex-Dividend DateNov 5, 2021
Financial Position
Bluebird Bio as a current ratio of 0.48, with Debt / Equity ratio of -8.99
Current Ratio0.48
Quick Ratio0.28
Debt to Market Cap3.51
Net Debt to EBITDA-0.82
Interest Coverage Ratio11.98
Taxes
In the past 12 months, Bluebird Bio has paid $16.05M in taxes.
Income Tax$16.05M
Effective Tax Rate0.03%
Enterprise Valuation
Bluebird Bio EV to EBITDA ratio is -1.12, with an EV/FCF ratio of -1.15.
EV to Sales3.60
EV to EBITDA-1.12
EV to Free Cash Flow-1.15
EV to Operating Cash Flow-1.16
Balance Sheet
Bluebird Bio has $70.65M in cash and marketable securities with $368.40M in debt, giving a net cash position of $297.75M billion.
Cash & Marketable Securities$70.65M
Total Debt$368.40M
Net Cash$297.75M
Net Cash Per Share$30.41
Tangible Book Value Per Share-$4.82
Margins
Gross margin is -6.65%, with operating margin of -322.72%, and net profit margin of -287.23%.
Gross Margin-6.65%
Operating Margin-322.72%
Pretax Margin-287.14%
Net Profit Margin-287.23%
EBITDA Margin-322.72%
EBIT Margin-314.08%
Analyst Forecast
The average price target for Bluebird Bio is $6.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$6.00
Price Target Upside44.93%
Analyst ConsensusHold
Analyst Count4
Revenue Growth Forecast184.12%
EPS Growth Forecast31.92%